Oral Vaccine Market Research Report by Type (Attenuated and Inactive), by Application (Cholera, HIV, Polio, Rabies, and Respiratory Infection), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Oral Vaccine Market is expected to grow from USD 14,072.38 Million in 2020 to USD 18,355.31 Million by the end of 2025.
2. The Global Oral Vaccine Market is expected to grow from EUR 12,338.93 Million in 2020 to EUR 16,094.28 Million by the end of 2025.
3. The Global Oral Vaccine Market is expected to grow from GBP 10,969.34 Million in 2020 to GBP 14,307.85 Million by the end of 2025.
4. The Global Oral Vaccine Market is expected to grow from JPY 1,501,880.29 Million in 2020 to JPY 1,958,977.25 Million by the end of 2025.
5. The Global Oral Vaccine Market is expected to grow from AUD 20,434.97 Million in 2020 to AUD 26,654.35 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Oral Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Oral Vaccine Market studied across Attenuated and Inactive.
Based on Application, the Oral Vaccine Market studied across Cholera, HIV, Polio, Rabies, Respiratory Infection, and Tuberculosis.
Based on End User, the Oral Vaccine Market studied across Clinics and Hospitals.
Based on Geography, the Oral Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Oral Vaccine Market including GlaxoSmithKline plc, Merck & Co., Inc., PaxVax Corporation, QU?MICA SUIZA S.A., Serum Institute of India Pvt. Ltd., and Shanghai BravoBio Co., Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Oral Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Oral Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Oral Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Oral Vaccine Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Oral Vaccine Market is expected to grow from USD 14,072.38 Million in 2020 to USD 18,355.31 Million by the end of 2025.
2. The Global Oral Vaccine Market is expected to grow from EUR 12,338.93 Million in 2020 to EUR 16,094.28 Million by the end of 2025.
3. The Global Oral Vaccine Market is expected to grow from GBP 10,969.34 Million in 2020 to GBP 14,307.85 Million by the end of 2025.
4. The Global Oral Vaccine Market is expected to grow from JPY 1,501,880.29 Million in 2020 to JPY 1,958,977.25 Million by the end of 2025.
5. The Global Oral Vaccine Market is expected to grow from AUD 20,434.97 Million in 2020 to AUD 26,654.35 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Oral Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Oral Vaccine Market studied across Attenuated and Inactive.
Based on Application, the Oral Vaccine Market studied across Cholera, HIV, Polio, Rabies, Respiratory Infection, and Tuberculosis.
Based on End User, the Oral Vaccine Market studied across Clinics and Hospitals.
Based on Geography, the Oral Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Oral Vaccine Market including GlaxoSmithKline plc, Merck & Co., Inc., PaxVax Corporation, QU?MICA SUIZA S.A., Serum Institute of India Pvt. Ltd., and Shanghai BravoBio Co., Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Oral Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Oral Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Oral Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Oral Vaccine Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ORAL VACCINE MARKET, BY TYPE
6.1. Introduction
6.2. Attenuated
6.3. Inactive
7. GLOBAL ORAL VACCINE MARKET, BY APPLICATION
7.1. Introduction
7.2. Cholera
7.3. HIV
7.4. Polio
7.5. Rabies
7.6. Respiratory Infection
7.7. Tuberculosis
8. GLOBAL ORAL VACCINE MARKET, BY END USER
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. AMERICAS ORAL VACCINE MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ORAL VACCINE MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. GlaxoSmithKline plc
13.2. Merck & Co., Inc.
13.3. PaxVax Corporation
13.4. QU?MICA SUIZA S.A.
13.5. Serum Institute of India Pvt. Ltd.
13.6. Shanghai BravoBio Co., Ltd.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ORAL VACCINE MARKET, BY TYPE
6.1. Introduction
6.2. Attenuated
6.3. Inactive
7. GLOBAL ORAL VACCINE MARKET, BY APPLICATION
7.1. Introduction
7.2. Cholera
7.3. HIV
7.4. Polio
7.5. Rabies
7.6. Respiratory Infection
7.7. Tuberculosis
8. GLOBAL ORAL VACCINE MARKET, BY END USER
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. AMERICAS ORAL VACCINE MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ORAL VACCINE MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. GlaxoSmithKline plc
13.2. Merck & Co., Inc.
13.3. PaxVax Corporation
13.4. QU?MICA SUIZA S.A.
13.5. Serum Institute of India Pvt. Ltd.
13.6. Shanghai BravoBio Co., Ltd.
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GLOBAL ORAL VACCINE MARKET: SCORES
TABLE 105. GLOBAL ORAL VACCINE MARKET: BUSINESS STRATEGY
TABLE 106. GLOBAL ORAL VACCINE MARKET: PRODUCT SATISFACTION
TABLE 107. GLOBAL ORAL VACCINE MARKET: RANKING
TABLE 108. GLOBAL ORAL VACCINE MARKET: MERGER & ACQUISITION
TABLE 109. GLOBAL ORAL VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 110. GLOBAL ORAL VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 111. GLOBAL ORAL VACCINE MARKET: INVESTMENT & FUNDING
TABLE 112. GLOBAL ORAL VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 113. GLOBAL ORAL VACCINE MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. ARGENTINA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. BRAZIL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. CANADA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MEXICO ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. AUSTRALIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. AUSTRALIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. CHINA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. CHINA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. INDIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. INDIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDONESIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDONESIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. JAPAN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. JAPAN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. MALAYSIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. MALAYSIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. PHILIPPINES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. PHILIPPINES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. THAILAND ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. THAILAND ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. FRANCE ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. FRANCE ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GERMANY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. GERMANY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. ITALY ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. ITALY ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. NETHERLANDS ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. NETHERLANDS ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. QATAR ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. QATAR ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. RUSSIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. RUSSIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SPAIN ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SPAIN ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. GLOBAL ORAL VACCINE MARKET: SCORES
TABLE 105. GLOBAL ORAL VACCINE MARKET: BUSINESS STRATEGY
TABLE 106. GLOBAL ORAL VACCINE MARKET: PRODUCT SATISFACTION
TABLE 107. GLOBAL ORAL VACCINE MARKET: RANKING
TABLE 108. GLOBAL ORAL VACCINE MARKET: MERGER & ACQUISITION
TABLE 109. GLOBAL ORAL VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 110. GLOBAL ORAL VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 111. GLOBAL ORAL VACCINE MARKET: INVESTMENT & FUNDING
TABLE 112. GLOBAL ORAL VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 113. GLOBAL ORAL VACCINE MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ORAL VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ORAL VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ORAL VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ORAL VACCINE MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ORAL VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 20. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2025
FIGURE 22. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 29. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2025
FIGURE 31. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 33. AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 34. AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 36. ARGENTINA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. BRAZIL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. CANADA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. MEXICO ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. UNITED STATES ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 42. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 44. AUSTRALIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CHINA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. INDONESIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. JAPAN ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. MALAYSIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. PHILIPPINES ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. THAILAND ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. FRANCE ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. GERMANY ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. ITALY ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. NETHERLANDS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. QATAR ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. RUSSIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SPAIN ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. GLOBAL ORAL VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL ORAL VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 69. GLOBAL ORAL VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ORAL VACCINE MARKET, BY TYPE
FIGURE 1. GLOBAL ORAL VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ORAL VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ORAL VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ORAL VACCINE MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ORAL VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 20. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2025
FIGURE 22. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 29. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2025
FIGURE 31. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 33. AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 34. AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 36. ARGENTINA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. BRAZIL ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. CANADA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. MEXICO ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. UNITED STATES ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 42. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 44. AUSTRALIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CHINA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. INDONESIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. JAPAN ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. MALAYSIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. PHILIPPINES ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. SOUTH KOREA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. THAILAND ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. FRANCE ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. GERMANY ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. ITALY ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. NETHERLANDS ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. QATAR ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. RUSSIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SAUDI ARABIA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SOUTH AFRICA ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SPAIN ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. UNITED KINGDOM ORAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. GLOBAL ORAL VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL ORAL VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 69. GLOBAL ORAL VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ORAL VACCINE MARKET, BY TYPE
